CPI-455 - KDM5 Demethylases Inhibitor. CAS# 1628208-23-0 Catalog No.:M60326-2S 4]triazin-7-yl)cyclohexanecarboxylic acid

4]triazin-7-yl)cyclohexanecarboxylic acid

suggesting rolapitant is a viable clinical candidate for this indication

Quizartinib inhibits FLT3 with low nanomolar potency in cellular assays and is highly selective when screened against the majority of the human protein kinome

Chemical Name: 6-(2-(tert-butyl)-5-(6-methylpyridin-2-yl)-1H-imidazol-4-yl)quinoxaline

61276-17-3

CPI-455 - KDM5 Demethylases Inhibitor. CAS# 1628208-23-0 Catalog No.:M60326-2S 4]triazin-7-yl)cyclohexanecarboxylic acidCPI 455, CAS No. 1628208 23 0, is a potent and selective inhibitor of KDM5 demethylases which reduces survival of drug tolerant cancer cells. CPI 455 mediated KDM5 inhibition, elevated global levels of H3K4 trimethylation (H3K4me3) and decreased the number of DTPs in multiple cancer cell line models treated with standard chemotherapy or targeted agents. Pretreatment of cancer cells with a KDM5 specific inhibitor results in the ablation of a